New Stock News | Future Wearable has re-submitted its application to the Hong Kong Stock Exchange, ranking first among domestic participants in China's smart relief wearable device industry.

According to the Hong Kong Stock Exchanges disclosure on August 19, Future Wearable Health Technology Co., Ltd. (referred to as Future Wearable) has applied to list on the main board of the Hong Kong Stock Exchange, with China Securities Co., Ltd. International as the exclusive sponsor. The company had previously submitted an application to the Hong Kong Stock Exchange on December 17, 2025. Company Overview According to its prospectus, Future Wearable is a health technology company that develops smart devices for relief, recovery, and daily health management, with products encompassing wearable devices and home products. Its product portfolio includes smart relief wearable devices, fitness recovery and shaping devices, smart health watches, and home products focused on health. Many of the company's products use established health technologies, such as medium frequency pulse and transcutaneous electrical nerve stimulation (TENS), both of which are commonly used therapies for pain relief and muscle recovery, integrating proven technologies into lightweight consumer devices for everyday health management. The companys products are specifically designed for daily life scenarios (including home, office, fitness, and travel) to meet needs such as easing discomfort, tracking key health metrics, supporting fitness recovery, and promoting family health, offering immediate relief and long-term health management. The company also applies technologies widely used in the medical field to consumer electronics, helping to bridge the gap between professional medical standards and personal health tools. The company is a renowned provider of smart relief wearable solutions for the neck and waist and also offers smart relief wearable devices suitable for the shoulders, waist, eyes, knees, and legs. The products combine pulse stimulation, kneading, thermal therapy, and red light technology to provide users with non-invasive daily relief. Users can adjust massage techniques and intensity through a mobile app and upgrade massage modes online. Core technologies include transcutaneous electrical nerve stimulation (TENS), which uses electrical stimulation to block pain signal transmission. As of May 31, 2026, the company has 1,554 registered patents worldwide, including 306 authorized invention patents. The company has also submitted 447 pending patent applications, including 384 invention patent applications. Its design capabilities have been recognized with numerous awards, including the Red Dot Design Award and the iF Design Award. According to Frost & Sullivan, based on total merchandise trading volume, the company ranks first among domestic participants in Chinas smart relief wearable device industry, with a domestic market share of 21.6% in 2025. The company has also played a leading role in formulating the national standard for Low-Frequency Massagers for Home and Similar Uses under the guidance of the Ministry of Industry and Information Technology, contributing to the formalization of industry standards for smart relief wearable devices. Financial Information Revenue For the fiscal years 2023, 2024, and 2025, and for the five months ending May 31, 2026, the company achieved revenues of approximately RMB 1.046 billion, RMB 1.045 billion, RMB 1.218 billion, and RMB 646 million, respectively. Gross Profit For the fiscal years 2023, 2024, and 2025, and for the five months ending May 31, 2026, the company recorded gross profits of approximately RMB 514 million, RMB 510 million, RMB 603 million, and RMB 311 million, respectively. Annual/Period Profit For the fiscal years 2023, 2024, and 2025, and for the five months ending May 31, 2026, the company recorded annual/period profits of approximately RMB 127 million, RMB 135 million, RMB 132 million, and RMB 62 million, respectively. Industry Overview Smart health wearable devices refer to intelligent devices that deeply integrate AI, the Internet of Things, high-precision biosensing, and big data analysis technologies, which can be worn on the human body to provide scenario-based, personalized, and closed-loop health management services. These devices continuously collect multidimensional physiological and environmental signals using high-precision sensors, analyze data using real-time artificial intelligence algorithms to generate actionable insights, promptly issue alerts, and provide personalized health recommendations or interventions. By 2025, the global sub-healthy population is estimated to reach 5.35 billion, accounting for 65.3% of the worlds population, indicating a widespread public health issue. Analysis by age structure shows that the highest morbidity rate is among those aged 25 to 44, at 88.7%, primarily due to immense work pressure, irregular lifestyles, and psychosocial stress. Following closely is the age group of 45 to 64, with a morbidity rate of 81.4%, influenced by cumulative health risks and long-term stress exposure. In 2020, the global smart wearable health device market reached USD 26.4 billion. By 2025, the global market for this technology is expected to grow to USD 46.6 billion, with a compound annual growth rate (CAGR) of 12.1% from 2020 to 2025. Driven by increased health awareness and growing emphasis on proactive health management through exercise and relaxation, the field of smart relief wearable devices has also experienced rapid growth. This market expanded from USD 4.9 billion in 2020 to USD 9.1 billion in 2025, with a CAGR of 13.1%, and is expected to reach USD 18.6 billion by 2030. The "Others" segment, including smart hearing aids and smart respiratory machines, is steadily growing as a separate category. Looking ahead, with breakthroughs in non-invasive detection technologies and improvements in healthcare payment systems, smart health watches are expected to become the central access point for personal health management. The market is projected to exceed USD 11 billion by 2030. As a crucial subfield of this market, smart health alert watches focus on proactive health management, emphasizing early disease detection and emergency intervention. These devices utilize high-precision sensors and AI algorithms to monitor critical health risks such as arrhythmias, abnormal blood pressure, and falls in real time, capturing pathological signals. They can assist with clinical decision-making or managing chronic diseases at home. Compared to generic smartwatches, they offer more specialized health monitoring and alert mechanisms, possessing stronger medical attributes. The market size has expanded from USD 1.7 billion in 2020 to USD 4.1 billion in 2025, with a CAGR of 19.7%. Chinas market for smart monitoring and tracking wearable devices also holds the largest share. In the CHINAHEALTHWISE wearable market, the two largest submarkets are smartwatches and smart patch monitoring devices. The former is projected to grow from RMB 22.4 billion in 2020 to RMB 42.6 billion in 2025, with a CAGR of 13.7%, expected to reach RMB 86.5 billion by 2030; the latter is expected to increase from RMB 900 million in 2020 to RMB 2.9 billion in 2025, with a CAGR of 25.2%, and to reach RMB 6.7 billion by 2030. The market size for CHINAHEALTHWISE watches is projected to grow from RMB 2.7 billion in 2020 to RMB 6.9 billion in 2025, with a CAGR exceeding 20.4%. By 2030, it is expected to reach RMB 22.8 billion, with a CAGR of over 25.5% from 2026 to 2030. Looking forward, as the consumer market becomes increasingly segmented and application scenarios expand, particularly with the growing proportion and penetration of users in lower-tier markets such as tier-three and tier-four cities, along with improved coverage of primary healthcare networks, the CHINAHEALTHWISE alert watch market is expected to experience further growth. The continuous expansion of community health service centers and village clinics has raised health monitoring awareness among residents in underserved areas, driving demand for smart health alert watches. Board of Directors Information The board will consist of six directors, including two executive directors, one non-executive director, and three independent non-executive directors. The term of the directors is three years, and they may be re-elected upon expiration of their term. Shareholding Structure As of the last practicable date (August 12, 2026), Mr. Liu, Ms. Xu, Little Goose Ballet, and Future Life Investment are the controlling shareholders of the company. Among them, Future Life Investment holds 69.67%, Mr. Liu holds 8.82% directly, Ms. Xu holds 5.45% directly, and Little Goose Ballet holds 2.00%. Together, they control 85.94% of the voting rights of the company under a consensus arrangement. Advisory Team Exclusive Sponsor: China Securities Co., Ltd. (International) Financing Co., Ltd. Company Legal Advisors: Regarding Hong Kong and U.S. law: Corporate Law (Hong Kong) Lawyers; Regarding Chinese law: Beijing Guofeng Law Firm. Exclusive Sponsor Legal Advisors: Regarding Hong Kong and U.S. law: JF Law Firm; Regarding Chinese law: Beijing Jing Tian Gong Cheng Law Firm. Reporting Accountant and Independent Auditor: Ernst & Young Independent Property Valuer: Jones Lang LaSalle (JLL) Valuation and Consulting Limited. Industry Consultant: Frost & Sullivan (Beijing) Consulting Co., Ltd. Shanghai Branch. Compliance Consultant: Hongbo Capital Ltd.